Yawei Z. Yuan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
TRIM32 drives head and neck squamous cell carcinoma progression via TP53 suppression and lysosomal/autophagy dysregulation.
Journal: Translational cancer research
Published: April 10, 2026
Astrocyte-microglia lactate shuttle restrains microglial phenotypic transition during myelin phagocytosis in radiation-induced brain injury.
Journal: Neuro-oncology advances
Published: January 23, 2026
CircRNA SLAIN1 is associated with reduced malignancy progression of glioblastoma and the M2-like polarization of tumor-associated macrophages via miR-1225-3p/NLRX1 axis.
Journal: International journal of biological macromolecules
Published: April 16, 2025
Prognostic value of tumour-stroma ratio in nasopharyngeal carcinoma: a two-center retrospective study.
Journal: Radiation oncology (London, England)
Published: February 17, 2025
Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response.
Journal: Annals of medicine
Published: October 10, 2024
Corrigendum: CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study.
Corrigendum: CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study.
Journal: Frontiers in molecular biosciences
Published: June 21, 2024
Stimuli-Responsive Peptide/siRNA Nanoparticles as a Radiation Sensitizer for Glioblastoma Treatment by Co-Inhibiting RELA/P65 and EGFR.
Journal: International journal of nanomedicine
Published: June 18, 2024
Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
Journal: Chronobiology international
Published: April 12, 2024
Corrigendum: Epigenetic-mediated downregulation of zinc finger protein 671 (ZNF671) predicts poor prognosis in multiple solid tumors.
Journal: Frontiers in oncology
Published: November 06, 2023
Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment.
Journal: Medicine
Published: November 01, 2022
Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Journal: Frontiers in immunology
Published: October 06, 2022
Therapeutic hyperthermia regulates complement C3 activation and suppresses tumor development through HSPA5/NFκB/CD55 pathway in nasopharyngeal carcinoma.
Journal: Clinical and experimental immunology
Published: October 03, 2022
Last Updated: 09/26/2026